Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial
References
- Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024 May 18;403(10440):2100–32.
- Kiran G, Mohan I, Kaur M, Ahuja S, Gupta S, Gupta R. Escalating ischemic heart disease burden among women in India: Insights from GBD, NCDRisC and NFHS reports. Am J Prev Cardiol. 2020 Jul 17;2:100035. DOI: 10.1016/j.ajpc.2020.100035
- India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018 Sep 12;6(12):e1339–51.
- Weintraub WS. The economic burden of illness. JAMA Netw Open. 2023;6(3):
e232663 . DOI: 10.1001/jamanetworkopen.2023.2663 - Marinho F. The impact of cardiovascular disease on economic loss. Arq Bras Cardiol. 2024;121(3):
e20240175 . DOI: 10.36660/abc.20240175 - World Economic Forum. Economics of non-communicable diseases in India [Internet]. 2014 [cited 2025 Jun 3]. Available from:
https://www3.weforum.org/docs/WEF_EconomicNonCommunicableDiseasesIndia_Report_2014.pdf . - Yadav J, Menon GR, John D. Disease-specific out-of-pocket payments, catastrophic health expenditure and impoverishment effects in India: An analysis of National Health survey data. Appl Health Econ Health Policy. 2021;19(5):769–82. DOI: 10.1007/s40258-021-00641-9
- Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, et al. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS ONE. 2011;6(6):
e20821 . DOI: 10.1371/journal.pone.0020821 - Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18(1):975. DOI: 10.1186/s12889-018-5806-x
- Hardy ST, Loehr LR, Butler KR, Chakladar S, Chang PP, Folsom AR, et al. Reducing the blood pressure–related burden of cardiovascular disease: Impact of achievable improvements in blood pressure prevention and control. J Am Heart Assoc. 2015;4(10). Available from:
https://www.ahajournals.org/doi/abs/10.1161/JAHA.115.002276 . - Jeong SM, Choi S, Kim K, Kim SM, Lee G, Park SY, et al. Effect of change in total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 2018;7(12). Available from:
https://www.ahajournals.org/doi/abs/10.1161/JAHA.118.008819 . - Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020 Jul;12(7):3866–76. DOI: 10.21037/jtd.2020.02.47
- Jeemon P, Harikrishnan S. Systolic blood pressure and cardiovascular health. Nat Med. 2022;28(10):2003–4. DOI: 10.1038/s41591-022-02005-9
- Limbachia J, Ajmeri M, Keating BJ, de Souza RJ, Anand SS. Effects of lifestyle interventions on cardiovascular risk factors in South Asians: A systematic review and meta-analysis. BMJ Open. 2022;12(12):
e059666 . DOI: 10.1136/bmjopen-2021-059666 - Vedanthan R, Bansilal S, Soto AV, Kovacic JC, Latina J, Jaslow R, et al. Family-based approaches to cardiovascular health promotion. J Am Coll Cardiol. 2016;67(14):1725–37. DOI: 10.1016/j.jacc.2016.01.036
- Jeemon P, Harikrishnan S, Sanjay G, Sivasubramonian S, Lekha TR, Padmanabhan S, et al. A PROgramme of lifestyle intervention in families for cardiovascular risk reduction (PROLIFIC Study): Design and rationale of a family based randomized controlled trial in individuals with family history of premature coronary heart disease. BMC Public Health. 2017;17:10. DOI: 10.1186/s12889-016-3928-6
- Jeemon P, Harikrishnan S, Ganapathi S, Sivasankaran S, Binukumar B, Padmanabhan S, et al. Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): An open-label, single-centre, cluster randomised controlled trial. Lancet Glob Health. 2021;9(10):e1442–50. DOI: 10.1016/S2214-109X(21)00319-3
- Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. BMC Med. 2022;20(1):23. DOI: 10.1186/s12916-021-02204-0
- Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med. 2009;33(5):337–43. DOI: 10.3109/07853890109002087
- Devlin N, Parkin D, Janssen B. Methods for analysing and reporting EQ-5D Data [Internet]. Cham, CH: Springer; 2020 [cited 2024 Mar 22]. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK565678/ . - Jyani G, Sharma A, Prinja S, Kar SS, Trivedi M, Patro BK, et al. Development of an EQ-5D value set for India using an extended design (DEVINE) study: The Indian 5-Level version EQ-5D value set. Value Health. 2022;25(7):1218–26. DOI: 10.1016/j.jval.2021.11.1370
- Chauhan AS, Guinness L, Bahuguna P, Singh MP, Aggarwal V, Rajsekhar K, et al. Cost of hospital services in India: a multi-site study to inform provider payment rates and Health Technology Assessment. BMC Health Serv Res. 2022;22(1):1343. DOI: 10.1186/s12913-022-08707-7
- Prinja S, Singh MP, Rajsekar K, Sachin O, Gedam P, Nagar A, et al. Translating research to policy: Setting provider payment rates for strategic purchasing under India’s national publicly financed health insurance scheme. Appl Health Econ Health Policy. 2021;19(3):353–70. DOI: 10.1007/s40258-020-00631-3
- Schreyögg J, Tiemann O, Stargardt T, Busse R. Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories. Health Econ. 2008;17(S1):S95–103. DOI: 10.1002/hec.1327
- International Monetary Fund. World Economic Outlook (April 2024) – GDP per capita, current prices [Internet]. International Monetary Fund; [cited 2024 May 31]. Available from:
https://www.imf.org/external/datamapper/PPPPC@WEO . - Sharma D, Prinja S, Aggarwal AK, Rajsekar K, Bahuguna P. Development of the Indian reference case for undertaking economic evaluation for health technology assessment. Lancet Reg Health – Southeast Asia. 2023;16:100241. Available from:
https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(23)00101-4/fulltext . - Briggs AH, Claxton K, Sculpher MJ.
Decision modelling for health economic evaluation . In: Oxford handbooks in health economic evaluation. Oxford: Oxford University Press; 2006. p. 237. DOI: 10.1093/oso/9780198526629.001.0001 - Sathish T, Oldenburg B, Thankappan KR, Absetz P, Shaw JE, Tapp RJ, et al. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program. BMC Med. 2020;18(1):251. DOI: 10.1186/s12916-020-01704-9
- Eriksson MK, Hagberg L, Lindholm L, Malmgren-Olsson EB, Österlind J, Eliasson M. Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch Intern Med. 2010;170(16):1470–9. DOI: 10.1001/archinternmed.2010.301
- Singh K, Kondal D, Menon VU, Varthakavi PK, Viswanathan V, Dharmalingam M, et al. Cost-effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial. Diabet Med. 2023;40(9):
e15074 . DOI: 10.1111/dme.15074 - Nieuwenhuijse EA, Vos RC, van den Hout WB, Struijs JN, Verkleij SM, Busch K, et al. The effect and cost-effectiveness of offering a combined lifestyle intervention for the prevention of cardiovascular disease in primary care: Results of the healthy heart stepped-wedge trial. Int J Environ Res Public Health. 2023;20(6):5040. DOI: 10.3390/ijerph20065040
- Wang H, Kenkel D, Graham M, Paul L, Folta S, Nelson M, et al. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas. BMC Health Serv Res. 2019;19. DOI: 10.1186/s12913-019-4117-y
- Krishnan A, Finkelstein EA, Kallestrup P, Karki A, Olsen MH, Neupane D. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): A retrospective analysis. Lancet Glob Health. 2019;7(10):e1367–74. DOI: 10.1016/S2214-109X(19)30338-9
- Augustovski F, Chaparro M, Palacios A, Shi L, Beratarrechea A, Irazola V, et al. Cost-effectiveness of a comprehensive approach for hypertension control in low-income settings in Argentina: Trial-based analysis of the hypertension control program in Argentina. Value Health. 2018;21(12):1357–64. DOI: 10.1016/j.jval.2018.06.003
- Whittington MD, Goggin K, Tsolekile L, Puoane T, Fox AT, Resnicow K, et al. Cost-effectiveness of Lifestyle Africa: An adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa. Glob Health Action. 2023;16(1):2212952. DOI: 10.1080/16549716.2023.2212952
- Thankappan KR, Sathish T, Tapp RJ, Shaw JE, Lotfaliany M, Wolfe R, et al. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med. 2018;15(6):
e1002575 . DOI: 10.1371/journal.pmed.1002575
DOI: https://doi.org/10.5334/gh.1450 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 16, 2025
Accepted on: Jul 11, 2025
Published on: Jul 31, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Ashis Samuel John, Sanjay Ganapathi, Sivadasanpillai Harikrishnan, Thoniparambil Ravindranathanpillai Lekha, Antony Stanley, Biju Soman, Thekkumkara Surendran Anish, Rujuta Hadaye, Jerin Jose Cherian, Nikhil Tandon, Dorairaj Prabhakaran, Panniyammakal Jeemon, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.